Join
Live feed
·
INSIDERFilingvia Quantisnow
Elicio Therapeutics Inc. logo

Chief Scientific Officer Demuth Peter was granted 20,800 shares, increasing direct ownership by 2,799% to 21,543 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ELTX· Elicio Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ELTX (Elicio Therapeutics Inc.) and more on Quantisnow.